The CEO of Statens Serum Institut (SSI), Mads Melbye, has resigned following a government-ordered investigation that found a “serious” violations of rules in connection with applications for vaccine ...

Now researchers from the University of Copenhagen, Statens Serum Institut and Rigshospitalet have come closer to explaining the phenomenon.

Statens Serum Institut is an enterprise under the Danish Ministry of the Interior and Health, and the Institute’s duties are partly integrated in the national Danish health services.

Although the virus mutates constantly, this variation prompted particular concern, according to scientists at Denmark’s Statens Serum Institut, because 12 of the people infected showed less ...

The researchers reviewed the national database at Statens Serum Institut and found 10 people living in urban areas of Denmark that had been colonized or hospitalized with MRSA.

Denmark’s largest study brings answers Researchers from Statens Serum Institut have now conducted an extensive study. Nearly 900,000 people over the age of 65 were included. The results are ...

The study was conducted by researchers at Denmark's top infectious disease authority, Statens Serum Institut (SSI). It analysed data from three million Danes gathered between Nov. 20 and Dec. 12.

The outbreak began in December 2021 and included 14 patients with a likely common source of infection, said the Statens Serum Institut. Ten people were hospitalized and an elderly patient died.

Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis Thursday February 14, 2:00 am ETÂ Scientific Advances in Vaccine Research may Lead to Improved Vaccine Against Leading Cause ...

One person has died in a Listeria outbreak in Denmark traced to a brand of fish cakes. Since mid-July, the Statens Serum Institut (SSI) has recorded seven patients who became ill from the same ...

The work, published Monday in the Annals of Internal Medicine, was conducted by researchers at the Statens Serum Institut in Copenhagen.

> Denmark's Statens Serum Institut and Maryland-based Aeras have kicked off a Phase I clinical trial of a vaccine to protect people who are latently infected with TB from developing the active ...